Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib

David S. Small,Wei Zhang,Jane Royalty,Ellen A. Cannady,Delyn Downs,Demetrio Ortega,Jeffrey G. Suico

Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib

2016

David S. Small
Wei Zhang
Jane Royalty
Ellen A. Cannady
Delyn Downs
Demetrio Ortega
Jeffrey G. Suico

Purpose The aim of this study is to investigate the effect of hepatic or renal impairment on the pharmacokinetics of a single 130-mg evacetrapib dose.

Keywords:

Medicine
Diabetes mellitus
Cholesterylester transfer protein
Hepatic impairment
Pharmacology
Anticholesteremic Agents
Internal medicine
Endocrinology
Evacetrapib
Pharmacokinetics
pharmacology toxicology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations